Anebulo Pharmaceuticals, Inc. - ANEB
Sector:
Healthcare
· Industry:
Pharmaceutical Preparations
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q4 2025
· Q3 2025
Value (USD)
Total reported value ($000)
$91.56M
QoQ value delta ($000)
+$36.02M
(+64.85%)
Implied price effect (QoQ)
+64.94%
Shares
Total shares
22,208,816
QoQ shares delta
-11,042
(-0.05%)
Total shares held by funds (by quarter)
Market chart (ANEB)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q4 2025)
Top 25 only
Full list
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| 22NW, LP | 84,760 | 15,467,300 | 35.68% |
| Nantahala Capital Management, LLC | 3,066 | 3,036,325 | 0.1% |
| MANGROVE PARTNERS IM, LLC | 2,550 | 2,525,252 | 0.21% |
| VANGUARD GROUP INC | 440 | 435,821 | 0.0% |
| MORGAN STANLEY | 403 | 399,404 | 0.0% |
| GEODE CAPITAL MANAGEMENT, LLC | 162 | 160,760 | 0.0% |
| Rangeley Capital, LLC | 50 | 50,000 | 0.04% |
| RENAISSANCE TECHNOLOGIES LLC | 25 | 25,098 | 0.0% |
| CITADEL ADVISORS LLC | 24 | 24,239 | 0.0% |
| BlackRock, Inc. | 24 | 23,790 | 0.0% |
| NORTHERN TRUST CORP | 22 | 21,994 | 0.0% |
| Ikarian Capital, LLC | 17 | 17,736 | 0.0% |
| STATE STREET CORP | 12 | 12,768 | 0.0% |
| Tower Research Capital LLC (TRC) | 3 | 3,230 | 0.0% |
| JPMORGAN CHASE & CO | 2 | 2,253 | 0.0% |
| UBS Group AG | 2 | 2,334 | 0.0% |
| BANK OF AMERICA CORP /DE/ | 0 | 382 | 0.0% |
| ROYAL BANK OF CANADA | 0 | 30 | 0.0% |
| FNY Investment Advisers, LLC | 0 | 100 | 0.0% |